bioRxiv Science⌕ Search

Biology subjects

Carvalho, M. B.

Publications and source records attributed to Carvalho, M. B..

3 recordsLinked to original sources

The Glycoproteome of Loxosceles Venom Reveals an Expanded Landscape of Animal Toxins

Spider venoms of the genus Loxosceles constitute a complex mixture of bioactive proteins and peptides associated with the major clinical manifestations of loxoscelism. Although significant advances have been made in the proteomic characterization of these toxins, studies addressing post-translational modifications, particularly glycosylation, and their potential impact on venom properties remain scarce. Here, we investigated the occurrence and characteristics of N-glycosylation in the venoms of Loxosceles gaucho, Loxosceles intermedia, and Loxosceles laeta. Using two-dimensional electrophoresis combined with glycoprotein-specific staining and LC-MS/MS, we identified glycosylation in different proteins biologically relevant to envenomation, predominantly belonging to the phospholipase D family, with distinct profiles among the species analyzed. Bottom-up glycoproteomic analysis of crude venoms using Byonic and a customized sequence database identified 88 N-glycosylated peptide sequences, primarily associated with lyases and hydrolases. Extensive microheterogeneity was detected at individual glycosylation sites, with paucimannosidic structures predominating alongside oligomannose and hybrid/complex N-glycans. Complementary enzyme-linked lectin assays supported the presence of distinct carbohydrate epitopes, including mannose, galactose, and N-acetylgalactosamine containing structures, and revealed 2,6-sialic acid-reactive motifs in two species. These findings establish N-glycosylation as an additional layer of molecular heterogeneity in Loxosceles venoms and provide a foundation for investigating its potential contribution to toxin properties and venom diversity.

biochemistry↗

Profile of the B cell receptor repertoire and antibody responses upon 17DD-YF vaccine boosting

Although the 17DD-YF vaccine is highly effective in conferring long-term immunity, recent studies suggest that booster doses may be necessary in endemic areas. In this study, we characterized the dynamics of the B cell repertoire following 17DD-YF booster vaccination and examined its impact on antibody kinetics. Using a combined approach of serological analysis and B cell receptor (BCR) sequencing, we investigated molecular features of the antibody response in four vaccinated individuals from a YFV-endemic region. Our results indicate that the booster induces a transient antibody response, with limited effect on the neutralization capacity against DENV1-4 and ZIKV. Notably, we observed a rapid clonal expansion of B cells within 14 days post-vaccination, predominantly involving IgA and IgG isotypes. However, this expansion was short-lived, with reduced magnitude and persistence of these lineages by day 28. Interestingly, some of the expanded lineages shared sequence similarity with previously characterized anti-DENV and anti-ZIKV antibodies, although further validation is required to assess their functional relevance and presence in circulating serum. Together, these findings highlight the transient nature and isotype composition of the antibody response following YFV revaccination and provide insights into the complex interplay between pre-existing immunity and recall responses in individuals living in endemic regions.

immunology↗

New insights of glycosylation role on variable domain of antibody structures

N-glycosylation at antibody variable domain (FvN-glyco) has emerged as an important modification for antibody function such as stability and antigen recognition, but it is also associated with autoimmune disease and IgE-mediated hypersensitivity reaction. However, the information related to its role and regulation is still scarce. Therefore, we investigated new insights in this regarding using solved antibodies structures presenting in the Protein Data Bank (PDB). From 130 FvN-glyco structures, we observed significant findings as a higher prevalence of N-glycosylation in human and mouse antibodies containing IGHV1-8 and IGHV2-2 germline genes, respectively. We also speculate the influence of activation-induced cytidine deaminase (AID) in introducing N-glycosylation sites during somatic hypermutation, specifically on threonine to asparagine substitution. Moreover, we highlight the enrichment of anti-HIV antibodies containing N-glycosylation at antibody variable domain and where we showed a possible important role of N-glycosylation, besides to antigen-antibody interactions, in antibody chain pair and antibody-antibody interactions. These could be a positive secondary effect of glycosylation to enhance antigen binding and further neutralization, including an additional mechanism to form Fab-dimers. Overall, our findings extend the knowledge on the characteristics and diverse role of N-glycosylation at antibody variable domain. Key PointsO_LIPrevalence of FvN-glyco in human IGHV1-8 and mouse IGHV2-2 germline genes. C_LIO_LIEnrichment of antibody FvN-glyco against virus, especially anti-HIV-1. C_LIO_LIFvN-glyco in the interface with antigen, antibody pair chain, and another antibody. C_LI

immunology↗